Inventor · disambiguated record
Colin R. Gardner
Also filed as: GARDNER COLIN · GARDNER COLIN R · GARDNER COLIN ROBER
18 granted patents·13 pending applications·616 citations·filing 1987–2024
95Inventor score
Files withMERCK & CO INC7UNIV JOHNS HOPKINS6LYNDRA THERAPEUTICS INC5KALA PHARMACEUTICALS INC4KATDARE ASHOK V2
Top patents by PatentIndex Score
31 records- 0198US9056057B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·56 cites·28 claims
- 0295US4767627ADrug delivery device which can be retained in the stomach for a controlled period of timeMERCK & CO INC·Filed 1987·Granted Aug 30, 1988·286 cites·12 claims
- 0390US12178920B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Dec 31, 2024·0 cites·15 claims
- 0490US11992552B2Geometric configurations for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2016·Granted May 28, 2024·5 cites·20 claims
- 0590US10058511B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2017·Granted Aug 28, 2018·2 cites·40 claims
- 0689US9393213B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·2 cites·28 claims
- 0787US11872318B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Jan 16, 2024·0 cites·22 claims
- 0887US11642317B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2020·Granted May 9, 2023·1 cites·31 claims
- 0987US4735804ADrug delivery device which can be retained in the stomach for a controlled period of timeMERCK & CO INC·Filed 1987·Granted Apr 5, 1988·109 cites·12 claims
- 1085US5853759AEffervescent alendronate formulationMERCK & CO INC·Filed 1997·Granted Dec 29, 1998·59 cites·5 claims
- 1184US12023406B2Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2024·2 cites·57 claims
- 1284US9737491B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 22, 2017·1 cites·21 claims
- 1383US11576859B2Gastric residence systems for sustained release of therapeutic agents and methods of use thereofLYNDRA THERAPEUTICS INC·Filed 2016·Granted Feb 14, 2023·3 cites·22 claims
- 1483US9532955B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 3, 2017·1 cites·20 claims
- 1583US4758436ADrug delivery device which can be retained in the stomach for a controlled period of timeMERCK & CO INC·Filed 1987·Granted Jul 19, 1988·80 cites·12 claims
- 1679US10736854B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 11, 2020·2 cites·37 claims
- 1775US2024342081A1Geometric configurations for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1874US2024382418A1Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1967US9393212B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·0 cites·31 claims
- 2059US2003003147A1Effer-vescent bisphosphonate formulationMERCK & CO INC·Filed 2002·Application pending·0 cites
- 2156US2001041165A1Effervescent bisphosphonate formulationMERCK & CO INC·Filed 2001·Application pending·0 cites
- 2254US2004137058A1Effervescent bisphosphonate formulationFiled 2004·Application pending·0 cites
- 2354US2007087052A1Effervescent bisphosphonate formulationKATDARE ASHOK V·Filed 2006·Application pending·0 cites
- 2452US2006148877A1Pharmaceutical formulations of celcoxibTRANSFORM PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2552US2006034921A1Effervescent bisphosphonate formulationKATDARE ASHOK V·Filed 2005·Application pending·0 cites
- 2647US2006111345A1Pharmaceutical compositions comprising a selective COX-2 inhibitor and a diureticTRANSFORM PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2742US2004106098A1Analysis of pharmaceutical solubility and stabilityTRANSFORM PHARMACEUTICALS·Filed 2003·Application pending·0 cites
- 2841US5980951AOral coated active drugsMERCK & CO INC·Filed 1997·Granted Nov 9, 1999·7 cites·8 claims
- 2941US2006188940A1Combinatorial hydrogel formulationCIMA MICHAEL·Filed 2006·Application pending·0 cites
- 3040US2010210027A9Method for determining effect of preformulation forms on their dissolution ratesCHEN HONGMING·Filed 2003·Application pending·0 cites
- 3134US2020030242A1Oral dosage form with drying agent for delivery of active agentENTREGA INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →